We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+12.19%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$16.9B
AUM Growth
-$1.28B
Cap. Flow
-$3.58B
Cap. Flow %
-21.13%
Top 10 Hldgs %
34.65%
Holding
323
New
13
Increased
38
Reduced
39
Closed
80

Top Buys

Rank Stock Value
1
INTU icon
Intuit
INTU
+$358M
2
CRM icon
Salesforce
CRM
+$251M
3
BABA icon
Alibaba
BABA
+$173M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$159M
5
SPGI icon
S&P Global
SPGI
+$119M

Top Sells

Rank Stock Value
1
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$497M
2
TWTR
Twitter, Inc.
TWTR
+$340M
3
ZEN
ZENDESK INC
ZEN
+$296M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$294M
5
META icon
Meta Platforms (Facebook)
META
+$245M

Sector Composition

Rank Sector Weight
1 Healthcare 32.5%
2 Technology 18.76%
3 Financials 14.5%
4 Industrials 8.33%
5 Communication Services 4.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GBT
301
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-450,000
Closed -$30.6M
BRG
302
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
– –
-486,902
Closed -$13M
ASZ.WS
303
DELISTED
Austerlitz Acquisition Corporation II Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
ASZ.WS
– –
-375,000
Closed -$38K
AUS.WS
304
DELISTED
Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
AUS.WS
– –
-125,000
Closed -$13K
CHNG
305
DELISTED
Change Healthcare Inc. Common Stock
CHNG
– –
-18,076,272
Closed -$497M
NLSN
306
DELISTED
Nielsen Holdings plc
NLSN
– –
-2,470,976
Closed -$68.5M
BHVN
307
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-1,947,820
Closed -$294M
9 10 11 12
13

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Farallon Capital Management held 323 positions worth $16.9B, down 7% from $18.2B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Farallon Capital Management withdrew a net $3.58B in Q4 2022, closing 80 positions and reducing 39 holdings. Its most notable exit was Change Healthcare Inc. Common Stock, an estimated $497M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 28% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in Intuit worth $351M.

  • Farallon Capital Management's largest Q4 2022 buy was Intuit: 902,100 shares worth $351M.
  • Farallon Capital Management added most to Salesforce in Q4 2022, an estimated $251M increase.
  • Farallon Capital Management's biggest Q4 2022 reduction was Clarivate, cutting an estimated $238M.
  • Farallon Capital Management fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $497M.
  • Farallon Capital Management's ten largest holdings make up 35% of its $16.9B portfolio in Q4 2022.
  • Farallon Capital Management opened 13 new positions and closed 80 in Q4 2022.
  • Farallon Capital Management's portfolio value fell 7% quarter-over-quarter to $16.9B.

Based on Farallon Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.